Announced Mon, 20 Apr · 13:45 IST

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 read with Schedule III and in furtherance to our intimation date April 16, 2026 and revised intimation dated April 17, 2026, we ....

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.1%1-day move
₹10.33
prior close
₹10.33
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.2+0.2+0.2+4.1+1.6-0.2-0.2-0.8-1.7-4.2+5.5+6.3-9.0
Up moveDown movePending
AI summary

Gennex Laboratories Ltd has convened an EGM on May 12, 2026 at 12:30 PM via video conferencing. The sole agenda item is the regularization of Ms. Khushbu Kachhawa as a Non-Executive Independent Woman Director. She was appointed as an Additional Director on February 14, 2026, replacing Ms. Shilpa Bung who resigned on the same date due to personal reasons and professional pre-occupations. Ms. Kachhawa's proposed term runs from February 14, 2026 until the conclusion of the 45th AGM in 2030, and she shall not be liable to retire by rotation. Remote e-voting will be open from May 8 to May 11, 2026, with the record date set as May 1, 2026. She holds a B.Com and CS Executive qualification with approximately 5 years of experience in business affairs and corporate secretarial matters.

Likely market impact

The appointment brings the board back to compliance with the requirement for a woman independent director following Ms. Bung's resignation. Shareholders should vote on this special resolution to formalize the board change.